Home › Funds › Yorkville Advisors Global, LP › RDHL
Yorkville Advisors Global, LP position in RDHL
RedHill Biopharma Ltd ADR · Health Care
Yorkville Advisors Global, LP reported holding 122,131 shares of RDHL (RedHill Biopharma Ltd ADR) in its Q2 2026 13F filing — a position valued at US$107K, representing 0.12% of its reported portfolio and ranking #31 among its reported holdings. Yorkville Advisors Global, LP has disclosed RDHL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Yorkville Advisors Global, LP's RDHL position evolved
Yorkville Advisors Global, LP first disclosed a stake in RDHL in Q4 2025 at 386,593 shares (US$398K). Across 3 filings, Yorkville Advisors Global, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 122,131 shares valued at US$107K — a reduction of -228,739 shares quarter over quarter.. Notable position changes include a 65% trim in Q2 2026 (shares fell 43% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 386.59K | $398.19K | New |
| Q1 2026 | 350.87K | $261.47K | Reduce |
| Q2 2026 | 122.13K | $106.68K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RDHL and 13F data
RDHL (RedHill Biopharma Ltd ADR) is a Health Care company. 11 other funds we track also report a position in RDHL. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Yorkville Advisors Global, LP
FAQ
How long has Yorkville Advisors Global, LP held RDHL?
Yorkville Advisors Global, LP has disclosed RDHL holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Yorkville Advisors Global, LP's current position in RDHL?
As of Q2 2026, Yorkville Advisors Global, LP holds 122.13K shares of RDHL (RedHill Biopharma Ltd ADR), valued at $106.68K, representing 0.12% of its reported portfolio and ranking #31.
Has Yorkville Advisors Global, LP been buying or selling RDHL?
In the latest 13F filing (Q2 2026), Yorkville Advisors Global, LP reduced its position in RDHL.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.